Handtevy Partners with ESO Solutions to Provide Seamless Access to Customized Pediatric Dosing Information
17 nov. 2016 08h00 HE
|
Handtevy - Pediatric Emergency Standards, Inc.
FORT LAUDERDALE, FL--(Marketwired - November 17, 2016) - Pediatric Emergency Standards Inc., creator of the Handtevy pediatric dosing system, announced a partnership with ESO Solutions today,...
Metabolon Launches Meta IMD™ Test to Speed Diagnosis of Inherited Metabolic Disorders
28 sept. 2016 10h05 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 28, 2016 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced today that Meta IMD™ is now available to physicians as a CLIA...
American Health Council Names Chai-Chih Huang, RN, MSN, NE-BC to Nursing Board
15 août 2016 17h29 HE
|
American Health Council
NEW YORK, Aug. 15, 2016 (GLOBE NEWSWIRE) -- Chai-Chih Huang, Director of Pediatric Nursing at Mattel Children’s Hospital at UCLA, has been selected to join the Nursing Board at the American Health...
Transwestern Raises $142,000 for National Philanthropy Partner, Make-A-Wish®
01 août 2016 17h16 HE
|
Transwestern Commercial Services, LLC
HOUSTON, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Transwestern’s Houston headquarters today announces it has raised more than $142,000 through various fundraising events held in its 34 offices...
Fate Therapeutics Announces FDA Fast Track Designation for ProTmune™
20 juin 2016 08h01 HE
|
Fate Therapeutics, Inc.
SAN DIEGO, June 20, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and...
Fate Therapeutics to Host Off-the-Shelf Cancer Immunotherapy Focus Session at 2016 Annual Meeting of International Society for Stem Cell Research
16 juin 2016 08h01 HE
|
Fate Therapeutics, Inc.
SAN DIEGO, June 16, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and...
Mattel Children's Hospital UCLA Recognized as 12th Pediatric Heart Failure Institute by Battelle Healthcare Colloquium
02 juin 2016 14h51 HE
|
Battelle
COLUMBUS, OH --(Marketwired - June 02, 2016) -
Battelle Healthcare Colloquium has recognized Mattel Children's Hospital UCLA as an Accredited Pediatric Heart Failure Institute. Mattel...
Fate Therapeutics Appoints Chris M. Storgard, M.D. as Chief Medical Officer
17 mai 2016 08h01 HE
|
Fate Therapeutics, Inc.
SAN DIEGO, May 17, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and...
Fate Therapeutics Announces Preclinical Data Highlighting Persistent Effector Function of Allogeneic Natural Killer Cell Cancer Immunotherapy
16 mai 2016 08h01 HE
|
Fate Therapeutics, Inc.
Adaptive NK Cell Therapy Advancing Toward First-in-Human Clinical Trial in Collaboration with University of Minnesota Program to be Presented Today at Innate Killer Summit 2016 SAN DIEGO, May 16,...
Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2016 Financial Results on May 9, 2016
02 mai 2016 16h01 HE
|
Fate Therapeutics, Inc.
SAN DIEGO, May 02, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and...